Home/Filings/4/0001127602-24-000650
4//SEC Filing

Louie Ngar Yee 4

Accession 0001127602-24-000650

CIK 0001878313other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 9:03 PM ET

Size

5.2 KB

Accession

0001127602-24-000650

Insider Transaction Report

Form 4
Period: 2023-12-31
Transactions
  • Award

    Stock Options

    2023-12-31+23,12723,127 total
    Exercise: $1.17From: 2023-12-31Exp: 2033-12-31Common Stock (23,127 underlying)
Footnotes (1)
  • [F1]The stock options, granted on December 31, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913264

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:03 PM ET
Size
5.2 KB